SUKANYA PILLAI VENKATACHALAM: Open Payments
NPI 1083878078 · PLEASANTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 36 payments from 12 companies in 2025. Trend: 2023 $278 · 2024 $348 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $172 |
| Axsome Therapeutics, Inc. | 6 | $171 |
| Neurocrine BioSciences, Inc. | 4 | $122 |
| Teva Pharmaceuticals USA, Inc. | 4 | $117 |
| Bausch Health US, LLC | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Lundbeck LLC | 2 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Supernus Pharmaceuticals, Inc. | 1 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
Products named: ARISTADA, Auvelity, INGREZZA, REXULTI, UZEDY, AUSTEDO XR, APLENZIN, FANAPT.
Industry payments across CA — which companies pay providers there.
